Pricing Log in Create free account

Apimeds Pharmaceuticals US, Inc. (APUS) vs Redhill Biopharma Ltd. (RDHL)

Apimeds Pharmaceuticals US, Inc. and Redhill Biopharma Ltd. are both Drug Manufacturers Specialty & Generic companies. Apimeds Pharmaceuticals US, Inc. and Redhill Biopharma Ltd. are of similar size ($4.1M and $3.8M). Redhill Biopharma Ltd. has the higher net margin (25.2% vs 0.00%) and the higher return on invested capital (0.00% vs −16.0%). Across the 10 metrics below, Redhill Biopharma Ltd. leads on 6 and Apimeds Pharmaceuticals US, Inc. on 4.

Valuation

Metric APUS RDHL Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S n/m 0.00 2.08
P/B 0.04 n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales n/m 6.43 2.87
Earnings yield (1,394.72%) (142,015.51%) (15.94%)
Free cash flow yield (295.94%) (231,394.02%) 0.00%

Profitability

Metric APUS RDHL Drug Manufacturers Specialty & Generic median
Gross margin — 35.16% 53.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 25.20% (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (100.13%) 0.00% (0.80%)
Return on assets (84.20%) 0.00% (1.67%)
Return on invested capital (15.96%) 0.00% 0.00%

Growth

Metric APUS RDHL Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (61.93%) 5.22%
EPS growth (last fiscal year) (205.56%) 97.91% 42.91%
Revenue growth, 5-year CAGR — (66.15%) 7.24%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric APUS RDHL Drug Manufacturers Specialty & Generic median
Debt to equity 0.08 0.00 0.04
Current ratio 0.51 0.34 2.41
Net debt to EBITDA 0.38 0.53 1.01

Dividend

Metric APUS RDHL Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric APUS RDHL Drug Manufacturers Specialty & Generic median
Market cap 4.12m 3.79m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack